"Benefits of Model-based Drug Development: A Rigorous, Planned Case Study."

Russell Reeve et al. (2015)

> Home

Details and statistics

DOI: 10.1080/03610918.2013.833232

access: closed

type: Journal Article

metadata version: 2022-05-30

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cssc/ReeveBXFTG15
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cssc/ReeveBXFTG15
Russell Reeve, Seth Berry, Wei Xiao, Bradley Ferguson, Marcel Thürk, Rüdiger Goetz:
Benefits of Model-based Drug Development: A Rigorous, Planned Case Study. Commun. Stat. Simul. Comput. 44(9): 2210-2222 (2015)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.